找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Glaucoma Drainage Devices; A Practical Illustra Monica Gandhi,Shibal Bhartiya Book 2019 Springer Nature Singapore Pte Ltd. 2019 Surgical te

[復(fù)制鏈接]
樓主: OAK
31#
發(fā)表于 2025-3-26 23:41:19 | 只看該作者
32#
發(fā)表于 2025-3-27 04:10:28 | 只看該作者
33#
發(fā)表于 2025-3-27 08:15:49 | 只看該作者
34#
發(fā)表于 2025-3-27 11:10:05 | 只看該作者
https://doi.org/10.1007/978-3-662-48417-3tained on maximally tolerable medical therapy and glaucomatous damage is still progressing or is deemed likely to progress, then surgery is suggested to the patient. Usually, the surgeon and the patient are faced with a dilemma to choose between a trabeculectomy and a glaucoma drainage device.
35#
發(fā)表于 2025-3-27 14:29:55 | 只看該作者
36#
發(fā)表于 2025-3-27 21:02:59 | 只看該作者
https://doi.org/10.1007/978-3-662-12009-5irreversible blindness. Therefore management of IOP may be required before, along with or after the patient has undergone PKP. Irreversible visual loss is seen due to optic nerve damage, and graft failure is caused by persistent rise in IOP leading to chronic corneal endothelial damage leading to corneal oedema and compromised graft clarity [1].
37#
發(fā)表于 2025-3-27 22:06:08 | 只看該作者
Ettore Majorana International Science Seriesprimary surgery of choice in refractory glaucomas like post-penetrating keratoplasty glaucoma, glaucoma following retinal surgery, neovascular glaucoma, and irido-corneal endothelial syndrome and in patients with scarred conjunctiva. They are frequently used in cases with failed trabeculectomy surgery also.
38#
發(fā)表于 2025-3-28 05:58:08 | 只看該作者
Preparing the Patient for the Glaucoma Drainage Device Surgery,tained on maximally tolerable medical therapy and glaucomatous damage is still progressing or is deemed likely to progress, then surgery is suggested to the patient. Usually, the surgeon and the patient are faced with a dilemma to choose between a trabeculectomy and a glaucoma drainage device.
39#
發(fā)表于 2025-3-28 08:10:13 | 只看該作者
40#
發(fā)表于 2025-3-28 10:45:29 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 06:40
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
英吉沙县| 肃南| 锡林郭勒盟| 栖霞市| 华安县| 阿拉善右旗| 镇康县| 漳州市| 安岳县| 天水市| 兰西县| 红桥区| 大庆市| 九龙城区| 屏东市| 合作市| 宜州市| 铜鼓县| 东城区| 壤塘县| 唐海县| 兴义市| 青田县| 清镇市| 日照市| 乃东县| 集贤县| 定陶县| 遵义市| 云阳县| 灵石县| 民县| 新泰市| 汉寿县| 贞丰县| 县级市| 灵台县| 米脂县| 敦煌市| 监利县| 湖南省|